s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
8-K
Current report filing
Filed
Friday, August 14, 2026
Period
Aug 14, 2026
Accession number
0001193125-26-350349
Documents
8-K
8-K
EX-99.1
EX-99.1
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header